Fedratinib Induces Spleen Responses and Reduces Symptom Burden in MPN-Associated Myelofibrosis and Low Platelet Counts in Ruxolitinib Naïve or Patients Treated w/ Ruxolitinib
Comments 0
Login to view comments.
Click here to Login